Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Visiopharm and Hamamatsu Announce Worldwide OEM Agreement

Published: Monday, July 09, 2012
Last Updated: Monday, July 09, 2012
Bookmark and Share
Reseller partnership for quantitative digital pathology.

Visiopharm and Hamamatsu have announced a non-exclusive worldwide original equipment manufacturer (OEM) agreement and reseller partnership for Visiopharm’s Quantitative Digital Pathology (QDP) solutions.

Under the partnership, Visiopharm will be an OEM for Hamamatsu’s new NDP.analyze software, a research tool for tissue image analysis, which is fully compatible with Visiopharm’s entire suite of QDP solutions.

Hamamatsu will market and sell the entire suite of QDP solutions, including CloudAnalysis, DeployedAnalysis, Stereology, and Application Protocol Packages (APPs) from Visiopharm’s new APPCenter.

NDP.analyze will be exhibited at Analytica 2012, 17th to 20th April 2012, in Munich, Germany.

Hamamatsu, who is known throughout the world for their NanoZoomer Digital Pathology (NDP) whole slide scanners, will expand their offering in digital pathology to include quantitative digital pathology.

The full range of analysis solutions are integrated with the NDP.serve data management software. The software will be available directly from Hamamatsu worldwide.

Masafumi Oshiro, Product Manager of Hamamatsu Photonics, stated “Hamamatsu is committed to provide complete solutions of high quality to its customers. Image analysis is becoming an increasingly important part of Digital Pathology. With the NDP.analyze and the software from Visiopharm fully integrated in the NDP environment, we are now able to provide a powerful image analysis solution. This powerful solution scales across the needs from individual academic researchers to large pharmaceutical companies with a regular and high-volume need for analysis. We are pleased to be able to offer image analysis APPs that provide a risk-free approach to image analysis for our customers and at the same time, provide immediate productivity with a very low learning curve.

NDP.analyze integrated with Visiopharm’s innovative solutions for QDP, will provide Hamamatsu customers with leading technology and flexible options, including analysis of NanoZoomer whole slide images in the Cloud and unlimited access to Visiopharm’s patent-pending APPCenter.

The APPCenter will provide both new and existing NanoZoomer and Visiopharm customers with innovative, affordable options for their deployed solutions, but also allow them to expand their efforts to collaborate and share data in the Cloud.

CloudAnalysis is an easy to budget solution for Hamamatsu customers who need access to sophisticated image analysis capabilities for a specific project which is limited in time.

Whether it is for a week, a month or longer, customers will only pay for analysis when they need it. Hamamatsu customers can now have instant access, and will be able to analyze whole slide images from work, home, or from anywhere.

Michael Grunkin PhD, CEO of Visiopharm, stated “We are very impressed with Hamamatsu and their innovative vision for digital pathology. The NanoZoomer is a very robust product capable of providing scanned images of a consistent high quality and with a very competitive scan speed. It is clear to us that Hamamatsu will play an important role in providing integrated and complete quality solutions to the research market. An OEM agreement and reseller partnership with Hamamatsu will expand the availability of Visiopharm’s QDP solutions worldwide, and enable the rapidly growing digital pathology market to work in an efficient, integrated digital workflow with Hamamatsu’s NanoZoomer Digital Pathology solutions.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Human Evolution Driven by Viruses
Study finds surprising percentage of protein adaptions in humans have been driven by viruses.
Earliest Sign of Alzheimer's Development Discovered
Researchers have identified the first physiological signs of late-onset Alzheimer's disease, underlining the importance of computational power in neurology.
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Drug Response Predicted by Cancer Cell Lines
Large-scale study could increase success rate of developing personalised cancer treatments.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!